Clinical Trials Directory

Trials / Completed

CompletedNCT01917968

Uphold LITE Post-Market Surveillance Study

A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of Uphold LITE Versus Native Tissue for the Treatment of Women With Anterior/Apical Pelvic Organ Prolapse

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
289 (actual)
Sponsor
Boston Scientific Corporation · Industry
Sex
Female
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare transvaginal mesh repair to traditional native tissue repair in women surgically treated for anterior and/or apical pelvic organ prolapse.

Detailed description

The primary objective is to evaluate clinical effectiveness of transvaginal repair with mesh (Uphold LITE) against traditional native tissue repair in women surgically treated for anterior and/or apical pelvic organ prolapse. Secondary objectives are to evaluate Uphold LITE-related complications and subject reported outcomes. The primary endpoint of the study is to achieve superiority of transvaginal repair with mesh (Uphold LITE) over native tissue repair at 36 months as compared to baseline. Success will be based on a composite of objective and subjective measures. Additionally, a co-primary endpoint of the study is to achieve non-inferiority of transvaginal repair with mesh (Uphold LITE) to native tissue repair for safety by comparing rates of serious device or serious procedure related complications between baseline and the 36 month time point. The secondary endpoints of the study include assessments of complications and subject reported outcomes.

Conditions

Interventions

TypeNameDescription
DEVICEUphold Lightweight Vaginal Support SystemPelvic organ prolapse repair via transvaginal mesh (Uphold LITE)
PROCEDURETraditional native tissue repairSarcrospinous ligament fixation or uterosacral ligament suspension and/or colporrhaphy

Timeline

Start date
2013-10-10
Primary completion
2020-02-12
Completion
2020-02-12
First posted
2013-08-07
Last updated
2021-05-20
Results posted
2021-03-15

Locations

28 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01917968. Inclusion in this directory is not an endorsement.